MCID: PRD006
MIFTS: 65

Prader-Willi Syndrome

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Reproductive diseases, Endocrine diseases, Fetal diseases

Aliases & Classifications for Prader-Willi Syndrome

MalaCards integrated aliases for Prader-Willi Syndrome:

Name: Prader-Willi Syndrome 54 12 72 23 50 24 25 56 29 13 52 41 42 14
Prader-Labhart-Willi Syndrome 23 50 24 25 56
Pws 23 50 24 25
Willi-Prader Syndrome 50 25 56
Prader Willi Syndrome 12

Characteristics:

Orphanet epidemiological data:

56
prader-willi syndrome
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: Antenatal,Neonatal; Age of death: normal life expectancy;

OMIM:

54
Miscellaneous:
decreased fetal activity
temperature instability
high pain threshold
excessive skin picking of sores
food related behavioral problems include excessive appetite and obsession with eating
breech position
behavioral problems including stubbornness and rage
sleep disturbance or sleep apnea (obstructive, central, or mixed)
unusual skill with jigsaw puzzle

Inheritance:
isolated cases


HPO:

32
prader-willi syndrome:
Inheritance sporadic


GeneReviews:

23
Penetrance Penetrance is complete...

Classifications:



Summaries for Prader-Willi Syndrome

MedlinePlus : 41 prader-willi syndrome (pws) is a rare genetic disorder. it causes poor muscle tone, low levels of sex hormones and a constant feeling of hunger. the part of the brain that controls feelings of fullness or hunger does not work properly in people with pws. they overeat, leading to obesity. babies with pws are usually floppy, with poor muscle tone, and have trouble sucking. boys may have undescended testicles. later, other signs appear. these include short stature poor motor skills weight gain underdeveloped sex organs mild intellectual and learning disabilities there is no cure for pws. growth hormone, exercise, and dietary supervision can help build muscle mass and control weight. other treatments may include sex hormones and behavior therapy. most people with pws will need specialized care and supervision throughout their lives. nih: national institute of child health and human development

MalaCards based summary : Prader-Willi Syndrome, also known as prader-labhart-willi syndrome, is related to angelman syndrome and schaaf-yang syndrome, and has symptoms including short stature, scoliosis and ataxia. An important gene associated with Prader-Willi Syndrome is NDN (Necdin, MAGE Family Member), and among its related pathways/superpathways are Circadian rythm related genes and Peptide hormone metabolism. The drugs Liraglutide and Hormone Antagonists have been mentioned in the context of this disorder. Affiliated tissues include skin, brain and testes, and related phenotypes are adipose tissue and behavior/neurological

Genetics Home Reference : 25 Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some people with Prader-Willi syndrome, particularly those with obesity, also develop type 2 diabetes mellitus (the most common form of diabetes).

NIH Rare Diseases : 50 prader-willi syndrome (pws) is a genetic condition that affects many parts of the body. infants with pws have severe hypotonia (low muscle tone), feeding difficulties, and slow growth. in later infancy or early childhood, affected children typically begin to eat excessively and become obese. other signs and symptoms often include short stature, hypogonadism, developmental delays, cognitive impairment, and distinctive behavioral characteristics such as temper tantrums, stubbornness, and obsessive-compulsive tendencies. pws is caused by missing or non-working genes on chromosome 15. most cases are not inherited and occur randomly. rarely, a genetic change responsible for pws can be inherited. management of pws generally depends on the affected person's age and symptoms. last updated: 7/7/2016

OMIM : 54
Prader-Willi syndrome is characterized by diminished fetal activity, obesity, muscular hypotonia, mental retardation, short stature, hypogonadotropic hypogonadism, and small hands and feet. It can be considered to be an autosomal dominant disorder and is caused by deletion or disruption of a gene or several genes on the proximal long arm of the paternal chromosome 15 or maternal uniparental disomy 15, because the gene(s) on the maternal chromosome(s) 15 are virtually inactive through imprinting. Horsthemke and Wagstaff (2008) provided a detailed review of the mechanisms of imprinting of the Prader-Willi/Angelman syndrome (105830) region. See also the chromosome 15q11-q13 duplication syndrome (608636), which shows overlapping clinical features. (176270)

Wikipedia : 72 Prader–Willi syndrome (PWS) is a genetic disorder due to loss of function of specific genes. In newborns... more...

GeneReviews: NBK1330

Related Diseases for Prader-Willi Syndrome

Diseases in the Prader-Willi Syndrome family:

Prader-Willi Syndrome Due to Paternal Deletion of 15q11q13 Type 1 Prader-Willi Syndrome Due to Paternal Deletion of 15q11q13 Type 2
Prader-Willi Syndrome Due to Translocation Prader-Willi Syndrome Due to Imprinting Mutation
Prader-Willi-Like Syndrome Due to Point Mutation Prader-Willi Syndrome Due to Paternal 15q11q13 Deletion
Prader-Willi Syndrome Due to Maternal Uniparental Disomy of Chromosome 15

Diseases related to Prader-Willi Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 127, show less)
id Related Disease Score Top Affiliating Genes
1 angelman syndrome 27.2 GABRA5 GABRB3 GH1 GHRL IGF1 IPW
2 schaaf-yang syndrome 12.2
3 prader-willi syndrome due to maternal uniparental disomy of chromosome 15 12.1
4 prader-willi syndrome due to paternal deletion of 15q11q13 type 1 12.1
5 prader-willi syndrome due to paternal deletion of 15q11q13 type 2 12.1
6 prader-willi syndrome due to translocation 12.1
7 prader-willi syndrome due to imprinting mutation 12.1
8 prader-willi syndrome due to paternal 15q11q13 deletion 12.1
9 hypotonia 11.5
10 floppy infant syndrome 11.2
11 infantile hypotonia 11.2
12 prader-willi habitus, osteopenia, and camptodactyly 11.2
13 childhood apraxia of speech 11.2
14 autoimmune enteropathy type 2 10.8 MAGEL2 NDN SNRPN
15 obesity 10.8
16 familial long qt syndrome 10.8 MAGEL2 NDN SNRPN
17 glycogen storage disease due to glucose-6-phosphatase deficiency 10.8 MAGEL2 NDN SNRPN
18 antenatal multiminicore disease with arthrogryposis multiplex congenita 10.8 MAGEL2 NDN SNRPN
19 hypotonia-speech impairment-severe cognitive delay syndrome 10.7 SNRPN UBE3A
20 maternally-inherited cardiomyopathy and hearing loss 10.5 IGF1 MKRN3
21 complement component 8 deficiency 10.5 IGF1 LEP MKRN3
22 chagas disease 10.5 GHRL LEP PYY
23 perinatal necrotizing enterocolitis 10.5 GHRL LEP PYY
24 mucolipidoses 10.4 GHRL LEP PYY
25 adrenal cortex disease 10.4 GH1 GHRL LEP
26 scoliosis 10.4
27 periampullary adenoma 10.4 GHRL IGF1 LEP
28 grubben de cock borghgraef syndrome 10.4 GH1 GHRL IGF1
29 survival motor neuron spinal muscular atrophy 10.4 GHRL IGF1 LEP
30 lipase deficiency, combined 10.4 GH1 IGF1
31 short bowel syndrome 10.4 GHRL IGF1 LEP
32 morbid obesity 10.4
33 neuronitis 10.3
34 skin meningioma 10.3 GH1 GHRL LEP
35 sleep disorder 10.3
36 hypogonadism 10.3
37 autism spectrum disorder 10.3
38 exostosis 10.3 GHRL IGF1 LEP
39 thyroiditis 10.2
40 sleep apnea 10.2
41 growth hormone deficiency 10.2
42 urethral stricture 10.2 GABRA5 GABRB3 NIPA2
43 hypothyroidism, congenital, nongoitrous 4 10.2 GH1 IGF1
44 down syndrome 10.2
45 hypersomnia 10.2
46 epilepsy 10.2
47 obstructive sleep apnea 10.2
48 precocious puberty 10.2
49 inherited metabolic disorder 10.2 GHRL IGF1 LEP PYY
50 lung cancer susceptibility 2 10.2 GH1 IGF1 LEP
51 radioulnar synostosis with amegakaryocytic thrombocytopenia 1 10.1 GH1 IGF1
52 intellectual disability 10.1
53 fragile x syndrome 10.1
54 cerebritis 10.1
55 mosaic trisomy 15 10.1
56 fetal parvovirus syndrome 10.1 IGF1 LEP OXT
57 thrombophilia 10.1 GH1 GHRL IGF1
58 precursor b lymphoblastic lymphoma/leukemia 10.1 GHRL IGF1 LEP
59 atypical autism 10.1 GABRB3 OXT UBE3A
60 insulin-like growth factor i 10.0
61 oculocutaneous albinism 10.0
62 hypothyroidism 10.0
63 central precocious puberty 10.0
64 cryptorchidism 10.0
65 panniculitis 10.0
66 polyhydramnios 10.0
67 albinism 10.0
68 gastric dilatation 10.0
69 glomerulonephritis 10.0
70 respiratory failure 10.0
71 protein s deficiency 9.9 GH1 IGF1
72 tay-sachs disease 9.9
73 spinal cord injury 9.9
74 intermittent explosive disorder 9.9
75 cardiomyopathy 9.9
76 congenital hypothyroidism 9.9
77 dementia 9.9
78 compartment syndrome 9.9
79 smith-magenis syndrome 9.9
80 ocular albinism 9.9
81 distal arthrogryposis 9.9
82 ectropion 9.9
83 periodontitis 9.9
84 systemic lupus erythematosus 9.9
85 norrie disease 9.9
86 fetal alcohol syndrome 9.9
87 trimethylaminuria 9.9
88 metabolic acidosis 9.9
89 lupus erythematosus 9.9
90 coronary artery disease 9.9
91 duchenne muscular dystrophy 9.9
92 congenital adrenal hyperplasia 9.9
93 hypothalamic disease 9.9
94 muscular dystrophy 9.9
95 seizure disorder 9.9
96 cerebellar hypoplasia 9.9
97 artery disease 9.9
98 constipation 9.9
99 osteoporosis 9.9
100 membranoproliferative glomerulonephritis 9.9
101 isodicentric 15 9.9
102 charge syndrome 9.9
103 hypomelanosis of ito 9.9
104 congenital hepatic fibrosis 9.9
105 cohen syndrome 9.9
106 dilated cardiomyopathy 9.9
107 periodontal disease 9.9
108 moebius syndrome 9.9
109 chromosome 15q deletion 9.9
110 obsessive-compulsive disorder 9.9
111 hepatitis 9.9
112 thrombosis 9.9
113 craniopharyngioma 9.9
114 endotheliitis 9.9
115 lymphedema 9.9
116 pancreatitis 9.9
117 congenital ectropion uveae 9.9
118 cardiac tamponade 9.9
119 infertility 9.9
120 slipped capital femoral epiphysis 9.9
121 chromosome 11p13 deletion syndrome, distal 9.9 GH1 GHRL IGF1 LEP PYY
122 dysbaric osteonecrosis 9.8 GABRB3 IPW MAGEL2 MKRN3 NDN SNRPN
123 maturity-onset diabetes of the young 6 9.7 GH1 GHRL IGF1 LEP PYY
124 von hippel-lindau syndrome 9.6 GH1 GHRL IGF1 LEP MAGEL2 PYY
125 autoimmune-related retinopathy and optic neuropathy 9.5 GABRA5 GABRB3 NDN OXT SNRPN UBE3A
126 sexual disorder 9.3 GABRA5 GABRB3 MAGEL2 NDN OXT SNRPN
127 roifman-chitayat syndrome 9.3 GABRA5 GABRB3 MAGEL2 NDN NIPA2 NPAP1

Graphical network of the top 20 diseases related to Prader-Willi Syndrome:



Diseases related to Prader-Willi Syndrome

Symptoms & Phenotypes for Prader-Willi Syndrome

Symptoms via clinical synopsis from OMIM:

54

Skeletal- Spine:
scoliosis
kyphosis

Neurologic- Central Nervous System:
sleep disturbances
learning disabilities
seizures
global developmental delay
behavioral problems
more
Skeletal:
osteoporosis
osteopenia

Genitourinary- Internal Genitalia Male:
cryptorchidism

Genitourinary- Internal Genitalia Female:
amenorrhea
oligomenorrhea

Skin Nails & Hair:
hypopigmentation

Head And Neck- Head:
dolichocephaly

Growth- Height:
normal birth length
length deceleration in first few months
mean adult male height, 155 cm
mean adult female height, 147 cm
steady childhood growth
more
Skin Nails & Hair- Skin:
fair skin
sun sensitivity

Growth- Weight:
failure to thrive in infancy
central obesity
onset of obesity from 6 months to 6 years

Head And Neck- Teeth:
early dental caries

Skeletal- Feet:
small feet (<10th percentile for height age)

Head And Neck- Eyes:
strabismus
myopia
hyperopia
upslanting palpebral fissures
almond-shaped eyes

Endocrine Features:
hyperinsulinemia
growth hormone deficiency
hypogonadotropic hypogonadism

Genitourinary- External Genitalia Female:
hypoplastic labia minora
hypoplastic clitoris

Head And Neck- Mouth:
thin upper lip
small-appearing mouth
down-turned corners of mouth
thick, viscous saliva

Skeletal- Hands:
clinodactyly
syndactyly
small hands (<25th percentile for height age)
narrow hands with straight ulnar border

Genitourinary- External Genitalia Male:
small penis
hypogonadotropic hypogonadism
scrotal hypoplasia

Respiratory:
hypoventilation
hypoxia

Skin Nails & Hair- Hair:
frontal hair upsweep
blonde to light brown hair

Voice:
hypernasal speech
weak or squeaky cry in infancy

Head And Neck- Face:
narrow bitemporal diameter

Abdomen- Gastroin testinal:
feeding problems in infancy requiring gavage feeds
decreased vomiting


Clinical features from OMIM:

176270

Human phenotypes related to Prader-Willi Syndrome:

56 32 (showing 94, show less)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 short stature 56 32 hallmark (90%) Frequent (79-30%) HP:0004322
2 scoliosis 56 32 frequent (33%) Frequent (79-30%) HP:0002650
3 ataxia 56 32 frequent (33%) Frequent (79-30%) HP:0001251
4 strabismus 56 32 frequent (33%) Frequent (79-30%) HP:0000486
5 seizures 56 32 very rare (1%) Frequent (79-30%) HP:0001250
6 microcephaly 56 32 frequent (33%) Frequent (79-30%) HP:0000252
7 intrauterine growth retardation 56 32 frequent (33%) Frequent (79-30%) HP:0001511
8 global developmental delay 56 32 hallmark (90%) Frequent (79-30%) HP:0001263
9 cryptorchidism 56 32 very rare (1%) Frequent (79-30%) HP:0000028
10 telecanthus 56 32 frequent (33%) Frequent (79-30%) HP:0000506
11 intellectual disability 56 32 frequent (33%) Frequent (79-30%) HP:0001249
12 downslanted palpebral fissures 56 32 frequent (33%) Frequent (79-30%) HP:0000494
13 high palate 56 32 frequent (33%) Frequent (79-30%) HP:0000218
14 obesity 56 32 hallmark (90%) Frequent (79-30%) HP:0001513
15 muscular hypotonia 56 32 frequent (33%) Frequent (79-30%) HP:0001252
16 delayed skeletal maturation 56 32 frequent (33%) Frequent (79-30%) HP:0002750
17 downturned corners of mouth 56 32 frequent (33%) Frequent (79-30%) HP:0002714
18 hypogonadotrophic hypogonadism 56 32 hallmark (90%) Frequent (79-30%) HP:0000044
19 hypoplasia of penis 56 32 frequent (33%) Frequent (79-30%) HP:0008736
20 bilateral single transverse palmar creases 56 32 frequent (33%) Frequent (79-30%) HP:0007598
21 behavioral abnormality 56 32 frequent (33%) Frequent (79-30%) HP:0000708
22 type i diabetes mellitus 56 32 frequent (33%) Frequent (79-30%) HP:0100651
23 short palm 56 32 hallmark (90%) Frequent (79-30%) HP:0004279
24 glomerulopathy 56 32 frequent (33%) Frequent (79-30%) HP:0100820
25 clinodactyly of the 5th finger 56 32 frequent (33%) Frequent (79-30%) HP:0004209
26 hypoplasia of the ear cartilage 56 32 frequent (33%) Frequent (79-30%) HP:0100720
27 abnormality of dental enamel 56 32 frequent (33%) Frequent (79-30%) HP:0000682
28 specific learning disability 56 32 hallmark (90%) Frequent (79-30%) HP:0001328
29 abnormal hair pattern 56 32 frequent (33%) Frequent (79-30%) HP:0010720
30 brachydactyly 32 frequent (33%) HP:0001156
31 recurrent respiratory infections 32 frequent (33%) HP:0002205
32 ventriculomegaly 32 frequent (33%) HP:0002119
33 myopia 32 occasional (7.5%) HP:0000545
34 micropenis 32 frequent (33%) HP:0000054
35 kyphosis 32 frequent (33%) HP:0002808
36 hyperinsulinemia 32 HP:0000842
37 osteoporosis 32 occasional (7.5%) HP:0000939
38 hypoplastic labia minora 32 frequent (33%) HP:0000064
39 infertility 32 hallmark (90%) HP:0000789
40 autism 32 very rare (1%) HP:0000717
41 esotropia 32 occasional (7.5%) HP:0000565
42 clinodactyly 32 HP:0030084
43 delayed puberty 32 frequent (33%) HP:0000823
44 motor delay 32 hallmark (90%) HP:0001270
45 osteopenia 32 occasional (7.5%) HP:0000938
46 psychosis 32 very rare (1%) HP:0000709
47 hypogonadism 32 HP:0000135
48 syndactyly 32 occasional (7.5%) HP:0001159
49 hypermetropia 32 HP:0000540
50 narrow forehead 32 frequent (33%) HP:0000341
51 growth hormone deficiency 32 hallmark (90%) HP:0000824
52 scrotal hypoplasia 32 very rare (1%) HP:0000046
53 generalized hypotonia 32 hallmark (90%) HP:0001290
54 decreased fetal movement 32 HP:0001558
55 dolichocephaly 32 HP:0000268
56 feeding difficulties in infancy 32 HP:0008872
57 primary amenorrhea 32 very rare (1%) HP:0000786
58 nasal speech 32 frequent (33%) HP:0001611
59 hypoventilation 32 HP:0002791
60 poor suck 32 hallmark (90%) HP:0002033
61 truncal obesity 32 HP:0001956
62 oligomenorrhea 32 frequent (33%) HP:0000876
63 abdominal obesity 32 HP:0012743
64 sleep apnea 32 frequent (33%) HP:0010535
65 precocious puberty 32 very rare (1%) HP:0000826
66 hip dysplasia 32 very rare (1%) HP:0001385
67 decreased muscle mass 32 frequent (33%) HP:0003199
68 narrow nasal bridge 32 frequent (33%) HP:0000446
69 thin upper lip vermilion 32 frequent (33%) HP:0000219
70 temperature instability 32 occasional (7.5%) HP:0005968
71 adrenal insufficiency 32 very rare (1%) HP:0000846
72 carious teeth 32 occasional (7.5%) HP:0000670
73 delayed speech and language development 32 hallmark (90%) HP:0000750
74 attention deficit hyperactivity disorder 32 frequent (33%) HP:0007018
75 failure to thrive in infancy 32 hallmark (90%) HP:0001531
76 clitoral hypoplasia 32 frequent (33%) HP:0000060
77 polyphagia 32 hallmark (90%) HP:0002591
78 type ii diabetes mellitus 32 very rare (1%) HP:0005978
79 poor gross motor coordination 32 HP:0007015
80 poor fine motor coordination 32 occasional (7.5%) HP:0007010
81 small hand 32 HP:0200055
82 cutaneous photosensitivity 32 frequent (33%) HP:0000992
83 generalized hypopigmentation 32 HP:0007513
84 short foot 32 hallmark (90%) HP:0001773
85 hypopigmentation of hair 32 very rare (1%) HP:0005599
86 upslanted palpebral fissure 32 occasional (7.5%) HP:0000582
87 brachydactyly syndrome 56 Frequent (79-30%)
88 impaired pain sensation 32 frequent (33%) HP:0007328
89 iris hypopigmentation 32 very rare (1%) HP:0007730
90 almond-shaped palpebral fissure 32 frequent (33%) HP:0007874
91 hypopigmentation of the skin 32 very rare (1%) HP:0001010
92 radial deviation of finger 32 occasional (7.5%) HP:0009466
93 frontal upsweep of hair 32 occasional (7.5%) HP:0002236
94 narrow palm 32 hallmark (90%) HP:0004283

MGI Mouse Phenotypes related to Prader-Willi Syndrome:

44 (showing 2, show less)
id Description MGI Source Accession Score Top Affiliating Genes
1 adipose tissue MP:0005375 9.5 GHRL IGF1 LEP MAGEL2 OXT PYY
2 behavior/neurological MP:0005386 9.32 PYY SNRPN UBE3A GABRA5 GABRB3 GHRL

Drugs & Therapeutics for Prader-Willi Syndrome

Drugs for Prader-Willi Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 73, show less)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Liraglutide Approved Phase 4,Phase 3 204656-20-2 44147092
2 Hormone Antagonists Phase 4,Phase 3
3 Hormones Phase 4,Phase 3
4 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
5 Hypoglycemic Agents Phase 4,Phase 3
6 Incretins Phase 4,Phase 3
7
Rimonabant Approved, Investigational Phase 3 168273-06-1, 158681-13-1 104850
8
Topiramate Approved Phase 3 97240-79-4 5284627
9
Oxytocin Approved, Vet_approved Phase 2, Phase 3,Phase 1 50-56-6 439302 53477758
10
Octreotide Approved, Investigational Phase 3 83150-76-9 383414 6400441
11
Somatostatin Approved Phase 3 38916-34-6, 51110-01-1 53481605
12 Cannabinoid Receptor Antagonists Phase 3
13 Neurotransmitter Agents Phase 3,Phase 2
14 Anticonvulsants Phase 3
15 Anti-Obesity Agents Phase 3
16 Neuroprotective Agents Phase 3
17 Protective Agents Phase 3
18 Oxytocics Phase 2, Phase 3,Phase 1
19 Antineoplastic Agents, Hormonal Phase 3
20 Gastrointestinal Agents Phase 3,Phase 1,Phase 2
21
Diazoxide Approved Phase 1, Phase 2 364-98-7 3019
22
Metoprolol Approved, Investigational Phase 2 37350-58-6, 51384-51-1 4171
23
Choline Approved, Nutraceutical Phase 1, Phase 2 62-49-7 305
24 Antimetabolites Phase 1, Phase 2
25 Adrenergic Agents Phase 2
26 Autonomic Agents Phase 2
27 Peripheral Nervous System Agents Phase 2
28 Antihypertensive Agents Phase 1, Phase 2
29 Hypolipidemic Agents Phase 1, Phase 2
30 Lipid Regulating Agents Phase 1, Phase 2
31 Nootropic Agents Phase 1, Phase 2
32 Vasodilator Agents Phase 1, Phase 2
33 Adrenergic Antagonists Phase 2
34 Adrenergic beta-1 Receptor Antagonists Phase 2
35 Adrenergic beta-Antagonists Phase 2
36 Anti-Arrhythmia Agents Phase 2
37 Sympatholytics Phase 2
38 Pharmaceutical Solutions Phase 2
39 methionine Nutraceutical Phase 2
40
Exenatide Approved, Investigational 141758-74-9 15991534
41
Cosyntropin Approved 16960-16-0 16129617
42
Epinephrine Approved, Vet_approved 51-43-4 5816
43
Hydrocortisone Approved, Vet_approved 50-23-7 5754 657311
44
Metyrapone Approved 54-36-4 4174
45 Racepinephrine Approved
46
Anastrozole Approved, Investigational 120511-73-1 2187
47
Menthol Approved 2216-51-5 16666
48 Glucagon-Like Peptide 1
49 Adrenergic Agonists
50 Adrenergic alpha-Agonists
51 Adrenergic beta-Agonists
52 Anti-Asthmatic Agents
53 Bronchodilator Agents
54 Cortisol succinate
55 Epinephryl borate
56 Hydrocortisone 17-butyrate 21-propionate
57 Hydrocortisone acetate
58 Mydriatics
59 Respiratory System Agents
60 Vasoconstrictor Agents
61 Anesthetics
62 Liver Extracts
63 insulin
64 Insulin, Globin Zinc
65 Arginine Vasopressin
66 Vasopressins
67 Aromatase Inhibitors
68 Estrogen Antagonists
69 Estrogens
70 Steroid Synthesis Inhibitors
71 Poke Nutraceutical
72 arginine Nutraceutical
73 Bifidobacterium Nutraceutical

Interventional clinical trials:

(showing 67, show less)

id Name Status NCT ID Phase Drugs
1 Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome? Completed NCT01298180 Phase 4 Growth hormone (Genotonorm® or Omnitrope®)
2 Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome Recruiting NCT03031626 Phase 4
3 Liraglutide Use in Prader-Willi Syndrome Terminated NCT01542242 Phase 4 Liraglutide
4 Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome Unknown status NCT02204163 Phase 3 Eutropin;Genotropin
5 Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome Unknown status NCT00603109 Phase 3 rimonabant;placebo
6 Growth Hormone Use in Adults With Prader-Willi Syndrome Unknown status NCT00444964 Phase 3 Nutropin AQ
7 Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks Completed NCT02810483 Phase 3 Topiramate;Placebo Comparator
8 Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome Recruiting NCT02804373 Phase 2, Phase 3 Oxytocin continuous;Placebo;Placebo continuous;Oxytocin
9 Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome Recruiting NCT02527200 Phase 3 liraglutide;placebo
10 Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome Terminated NCT02179151 Phase 3 ZGN-440 for Injectable Suspension;ZGN-440 Placebo for Injectable Suspension
11 Prader-Willi Syndrome and Appetite Terminated NCT00175305 Phase 3 Sandostatin LAR
12 Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome Completed NCT02311673 Phase 2 RM-493;Placebo
13 Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome Completed NCT02034071 Phase 1, Phase 2 DCCR;Placebo
14 Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome Completed NCT01968187 Phase 2 FE 992097;Placebo
15 Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project Completed NCT00742664 Phase 1, Phase 2
16 An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome Completed NCT01818921 Phase 2 ZGN-440 sterile diluent;1.2 mg ZGN-440 for injectable suspension;1.8 mg ZGN-440 for injectable suspension
17 Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo Completed NCT01038570 Phase 2 Syntocinon®/- Spray;Physiological serum (Sodium chloride)
18 Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants Completed NCT02205034 Phase 1, Phase 2 oxytocin
19 Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies Completed NCT01548521 Phase 1, Phase 2 Oxytocin
20 Intranasal Oxytocin for Infants With Prader-Willi Syndrome Recruiting NCT03245762 Phase 1, Phase 2 Oxytocin;Placebo
21 Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) Recruiting NCT03149445 Phase 2 Tesofensine/Metoprolol;Placebos
22 Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Active, not recruiting NCT02629991 Phase 2 Intranasal Oxytocin (IN-OXT);Matched Placebo
23 A Study of GLWL-01 in Patients With Prader-Willi Syndrome Not yet recruiting NCT03274856 Phase 2 GLWL-01;Placebo
24 Cannabidiol Oral Solution for The Treatment of Subjects With Prader-Willi Syndrome Not yet recruiting NCT02844933 Phase 2 Cannabidiol;Placebo
25 Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Not yet recruiting NCT03197662 Phase 2 Intranasal Oxytocin (IN-OXT);Matched Placebo
26 A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR) Not yet recruiting NCT02893618 Phase 2 Diazoxide choline controlled-release tablet
27 Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome Unknown status NCT02297022 Phase 1
28 Oxytocin Trial in Prader-Willi Syndrome Completed NCT02013258 Phase 1 Intranasal oxytocin
29 Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers Completed NCT01401244 Phase 1 somatropin;somatropin
30 Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts Active, not recruiting NCT02567357 Phase 1
31 Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell Unknown status NCT02205450 Recombinant Somatropin
32 Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome Unknown status NCT00551343 Exenatide
33 Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome Unknown status NCT02368379
34 Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study Unknown status NCT02058342
35 Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome Unknown status NCT00808548
36 PREPL in Health and Disease Unknown status NCT02263781
37 Hypoglycemia in Prader-Willi Syndrome Completed NCT01897363
38 Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity Completed NCT00375089
39 Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome Completed NCT00065923 Topiramate
40 Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome Completed NCT00705172 somatropin
41 Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome Completed NCT01479322
42 Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome Completed NCT01622751
43 Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls Completed NCT00932932
44 Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome Completed NCT01444898 Exenatide
45 Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome Completed NCT00800852
46 Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome Completed NCT00372125 Norditropin SimpleXx
47 Prader-Willi Syndrome Macronutrient Study Completed NCT02011360
48 The Intestinal Function in People With Prader-Willi Syndrome Completed NCT01523288
49 Ghrelin Suppression by Octreotide in Prader-Willi Completed NCT01613495 Placebo;Octreotide
50 Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome Completed NCT00474643
51 Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity Completed NCT01404624
52 Macronutrient Regulation of Ghrelin and Peptide YY Completed NCT02464514
53 Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW Completed NCT02670694
54 Brain-Derived Neurotrophic Factor in Obesity and Brain Function Completed NCT01517048
55 Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes Completed NCT00004351
56 Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants. Recruiting NCT03081832 Oxytocin
57 Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years Recruiting NCT03114371 Oxytocin;Placebo;Oxytocin
58 Register of Patients With Prader-Willi Syndrome Recruiting NCT02829684
59 Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory Recruiting NCT03101826
60 Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome Recruiting NCT01863017
61 PWS European Blood Bank for Infants and Controls From 0 to 48 Months Recruiting NCT02529085
62 Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing (OBEXOME) Recruiting NCT02510989
63 SNP-based Microdeletion and Aneuploidy RegisTry (SMART) Recruiting NCT02381457
64 Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome Active, not recruiting NCT01520467 Anastrozole;Placebo
65 Post Exercise Irisin Levels in PWS Patients Not yet recruiting NCT02728544
66 B. Lactis B94 Effects of Gastrointestinal Function Not yet recruiting NCT03277157
67 Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) Terminated NCT00399893 Octreotide;Placebo

Search NIH Clinical Center for Prader-Willi Syndrome

Cochrane evidence based reviews: prader-willi syndrome

Genetic Tests for Prader-Willi Syndrome

Genetic tests related to Prader-Willi Syndrome:

id Genetic test Affiliating Genes
1 Prader-Willi Syndrome 29 24

Anatomical Context for Prader-Willi Syndrome

MalaCards organs/tissues related to Prader-Willi Syndrome:

39
Skin, Brain, Testes, Bone, Liver, Pituitary, Eye

Publications for Prader-Willi Syndrome

Articles related to Prader-Willi Syndrome:

(showing 840, show less)
id Title Authors Year
1
Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study. ( 28371242 )
2017
2
A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research. ( 28721467 )
2017
3
Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome. ( 28659150 )
2017
4
Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience. ( 28854950 )
2017
5
SNORD116 deletions cause Prader-Willi syndrome with a mild phenotype and macrocephaly. ( 28266014 )
2017
6
"La Monstrua Desnuda": an artistic textbook representation of Prader-Willi syndrome in a painting of Juan CarreA+o de Miranda (1680). ( 28239764 )
2017
7
Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi Syndrome: a case report. ( 28938886 )
2017
8
Clinical and Molecular Characterization of Prader-Willi Syndrome. ( 28660389 )
2017
9
Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome? ( 27941250 )
2017
10
Gastric Dilatation and Abdominal Compartment Syndrome in a Child with Prader-Willi Syndrome. ( 28588153 )
2017
11
Respiratory Failure due to Severe Obesity and Kyphoscoliosis in a 24-Year-Old Male with Molecularly Confirmed Prader-Willi Syndrome in Tertiary Hospital in Northern Tanzania. ( 28487784 )
2017
12
Assessing the Clinical Utility of SNP Microarray for Prader-Willi Syndrome due to Uniparental Disomy. ( 28746920 )
2017
13
Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. ( 27941249 )
2017
14
Effectiveness of Adenotonsillectomy and Risk of Velopharyngeal Insufficiency in Children With Prader-Willi Syndrome. ( 28895429 )
2017
15
Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. ( 28634363 )
2017
16
Investigating Autism-Related Symptoms in Children with Prader-Willi Syndrome: A Case Study. ( 28264487 )
2017
17
Incidental memory for faces in children with different genetic subtypes of Prader-Willi syndrome. ( 28338743 )
2017
18
Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome. ( 28331554 )
2017
19
Diagnoses and characteristics of autism spectrum disorders in children with Prader-Willi syndrome. ( 28592997 )
2017
20
Severe Short Stature in an Adolescent Male with Prader-Willi Syndrome and Congenital Adrenal Hyperplasia: A Therapeutic Conundrum. ( 28638668 )
2017
21
Microstructural white matter tract alteration in Prader-Willi syndrome: A diffusion tensor imaging study. ( 28834083 )
2017
22
Rigidity in routines and the development of resistance to change in individuals with Prader-Willi syndrome. ( 28266087 )
2017
23
Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis. ( 28510708 )
2017
24
Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database. ( 28323917 )
2017
25
Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens. ( 28427039 )
2017
26
At-Home Transcranial Direct Current Stimulation in Prader-Willi Syndrome With Severe Intellectual Disability: A Case Study. ( 28383347 )
2017
27
The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. ( 28285653 )
2017
28
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome. ( 28600576 )
2017
29
Box C/D small nucleolar RNA genes and the Prader-Willi syndrome: a complex interplay. ( 28296064 )
2017
30
Physical activity and maximal oxygen uptake in adults with Prader-Willi syndrome. ( 28299717 )
2017
31
The dilemma of diagnostic testing for Prader-Willi syndrome. ( 28164030 )
2017
32
Adult-onset deletion of the Prader-Willi syndrome susceptibility gene Snord116 in mice results in reduced feeding and increased fat mass. ( 28503414 )
2017
33
Evaluating the Feasibility of a Play-Based Telehealth Intervention Program for Children with Prader-Willi Syndrome. ( 28612246 )
2017
34
Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion. ( 28659728 )
2017
35
Cognition in people with Prader-Willi syndrome: Insights into genetic influences on cognitive and social development. ( 27836461 )
2017
36
Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2. ( 28626083 )
2017
37
Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey. ( 28682308 )
2017
38
Prader-Willi Syndrome: Background and Management. ( 28494825 )
2017
39
Adult Prader-Willi Syndrome: An Update on Management. ( 27375909 )
2016
40
Effect of genotype and previous growth hormone treatment on adiposity in adults with Prader-Willi syndrome. ( 27662437 )
2016
41
A Rare Association of Obesity, Diabetes Mellitus and Bilateral Cryptorchidism: Prader - Willi Syndrome. ( 27805351 )
2016
42
Behavioral and emotional manifestations in a child with Prader-Willi syndrome. ( 27605867 )
2016
43
Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome. ( 28007570 )
2016
44
An unusual case of adolescent type 2 diabetes mellitus: Prader-Willi syndrome. ( 27453871 )
2016
45
Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy. ( 27426895 )
2016
46
Nutritional intervention with hypocaloric diet for weight control in children and adolescents with Prader-Willi Syndrome. ( 26970733 )
2016
47
Diagnosis and treatment of GH deficiency in Prader-Willi syndrome. ( 27974191 )
2016
48
Case report: severe asymptomatic hyponatremia in Prader-Willi Syndrome. ( 26888082 )
2016
49
Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls. ( 27518917 )
2016
50
Association between physical activity and bone in children with Prader-Willi syndrome. ( 27159915 )
2016
51
Indices of Adiposity by Weight Status in Children With and Without Prader-Willi Syndrome: 3670 Board #109 June 4, 8: 00 AM - 9: 30 AM. ( 27362036 )
2016
52
Use of a venting PEG tube in the management of recurrent acute gastric dilatation associated with Prader-Willi syndrome. ( 26763981 )
2016
53
Deactivation of the left dorsolateral prefrontal cortex in Prader-Willi syndrome after meal consumption. ( 27121248 )
2016
54
Paroxysmal Tonic Upward Gaze at Adolescence: A Girl with Prader-Willi Syndrome. ( 28466625 )
2016
55
Sedentary Behavior is Negatively Associated with Hip Bone Mineralization in Youth with Prader-Willi Syndrome: 1134 Board #8 June 1, 3: 15 PM - 5: 15 PM. ( 27584290 )
2016
56
Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey. ( 27854358 )
2016
57
Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite. ( 27931246 )
2016
58
Respiratory Complications in Children with Prader Willi Syndrome. ( 27839656 )
2016
59
Baroreflex Dysfunction in Prader Willi Syndrome. ( 27134867 )
2016
60
Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader-Willi syndrome. ( 28004416 )
2016
61
Drug-induced sleep endoscopy in children with Prader-Willi syndrome. ( 27059377 )
2016
62
Economic burden and health-related quality of life associated with Prader-Willi syndrome in France. ( 27174598 )
2016
63
A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy. ( 27982202 )
2016
64
Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects. ( 27659713 )
2016
65
Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome. ( 28024084 )
2016
66
A mindfulness-based intervention for self-management of verbal and physical aggression by adolescents with Prader-Willi syndrome. ( 27019027 )
2016
67
Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study. ( 27381990 )
2016
68
Quality of life in children with Prader Willi Syndrome: Parent and child reports. ( 27433979 )
2016
69
Life Satisfaction Among Mothers of Individuals with Prader-Willi Syndrome. ( 26883647 )
2016
70
Benefits and Limitations of Prenatal Screening for Prader-Willi Syndrome. ( 27537837 )
2016
71
Weight control and behavior rehabilitation in a patient suffering from Prader Willi syndrome. ( 27036220 )
2016
72
Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome. ( 27377921 )
2016
73
Does the Genetic Cause of Prader-Willi Syndrome Explain the Highly Variable Phenotype? ( 28694852 )
2016
74
Prader-Willi syndrome in neonates: twenty cases and review of the literature in Southern China. ( 27506196 )
2016
75
Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial. ( 27486141 )
2016
76
Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: A rebuttal to the conclusions by Kuppens et al. ( 27037909 )
2016
77
Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent. ( 27028699 )
2016
78
Microscopic structure of dental hard tissues in primary and permanent teeth from individuals with Prader-Willi syndrome. ( 26913968 )
2016
79
Reply to Letter to the Editor: Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome, a rebuttal to the conclusions by Kuppens et al. ( 27144882 )
2016
80
Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics. ( 27857842 )
2016
81
Aripiprazole in the Treatment of Obsessive Compulsive Disorder and Aggressive Behaviors in a Child With Prader Willi Syndrome: A Case Report. ( 27518476 )
2016
82
Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. ( 27481444 )
2016
83
Prader-Willi Syndrome due to an Unbalanced de novo Translocation t(15;19)(q12;p13.3). ( 27894106 )
2016
84
High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome. ( 27146407 )
2016
85
Decline of CSF orexin (hypocretin) levels in Prader-Willi syndrome. ( 26738920 )
2016
86
Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings. ( 26615966 )
2016
87
Erratum: Postprandial metabolism in adults with prader-willi syndrome. ( 27460716 )
2016
88
Beneficial effects of growth hormone in young adults with Prader-Willi syndrome: a 2-year cross-over trial. ( 27552545 )
2016
89
Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome. ( 26841067 )
2016
90
Response to letter to the editor by Scheimann, Miller, and Glaze: Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi Syndrome: A matched control study. ( 27986576 )
2016
91
Mechanisms of obesity in Prader-Willi syndrome. ( 27863129 )
2016
92
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. ( 27038627 )
2016
93
Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene. ( 28933382 )
2016
94
Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome. ( 27071367 )
2016
95
Deficits in voice and multisensory processing in patients with Prader-Willi syndrome. ( 26994593 )
2016
96
Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial. ( 27852283 )
2016
97
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. ( 27900261 )
2016
98
Ambient temperature modulates the effects of the Prader-Willi syndrome candidate gene Snord116 on energy homeostasis. ( 27823858 )
2016
99
Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls. ( 27214028 )
2016
100
Growth Hormone Therapy in Adults with Prader-Willi Syndrome. ( 28943608 )
2015
101
Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome. ( 25926624 )
2015
102
Behavioural characteristics of the Prader-Willi syndrome related biallelic Snord116 mouse model. ( 26259850 )
2015
103
Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments. ( 26475993 )
2015
104
Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome. ( 26334732 )
2015
105
Concurrent diagnoses of Prader-Willi syndrome and GM2 gangliosidosis caused by uniparental disomy of chromosome 15. ( 25900722 )
2015
106
Bone mineral density in children and adolescents with prader-willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. ( 25668198 )
2015
107
Relationship between Antipsychotics and Weight in Patients with Prader-Willi Syndrome. ( 25809177 )
2015
108
A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome. ( 25677112 )
2015
109
Comparative molecular approaches in Prader-Willi syndrome diagnosis. ( 26335514 )
2015
110
Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial. ( 25764996 )
2015
111
Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. ( 26345685 )
2015
112
Evaluation of the hypothalamic-pituitary-adrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome. ( 26329144 )
2015
113
Obstructive sleep apnea in Prader-Willi syndrome: risks and advantages of adenotonsillectomy. ( 26429118 )
2015
114
Autism spectrum disorder in Prader-Willi syndrome: A systematic review. ( 26331980 )
2015
115
Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals. ( 25925349 )
2015
116
Visual-motor integration in children with Prader-Willi syndrome. ( 25871504 )
2015
117
Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome. ( 26323055 )
2015
118
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome. ( 25710568 )
2015
119
Biofeedback therapy for chronic constipation in a patient with Prader-Willi syndrome. ( 26423048 )
2015
120
Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study. ( 26279206 )
2015
121
Food for thought: Complications of acute gastric distension in Prader-Willi syndrome. ( 25835332 )
2015
122
High plasma neurotensin levels in children with Prader-Willi syndrome. ( 25847417 )
2015
123
Sleep disordered breathing in patients with Prader-Willi syndrome: A multicenter study. ( 25851435 )
2015
124
Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome. ( 26259133 )
2015
125
Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. ( 25736874 )
2015
126
Dietary aspects related to health and obesity in Williams syndrome, Down syndrome, and Prader-Willi syndrome. ( 25653019 )
2015
127
Birth seasonality in Korean Prader-Willi syndrome with chromosome 15 microdeletion. ( 25883926 )
2015
128
Stress and coping in parents of children with Prader-Willi syndrome: Assessment of the impact of a structured plan of care. ( 25755074 )
2015
129
Response to the Letter to the Editor: laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi Syndrome: a matched control study. ( 26575355 )
2015
130
Deletion of the Snord116/SNORD116 Alters Sleep in Mice and Patients with Prader-Willi Syndrome. ( 26446116 )
2015
131
Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome. ( 25989955 )
2015
132
Gall bladder agenesis in Prader Willi syndrome. ( 25729700 )
2015
133
Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity? ( 25840793 )
2015
134
Phenotype of a child with Angelman syndrome born to a woman with Prader-Willi syndrome. ( 25832033 )
2015
135
Growth patterns of Chinese patients with Prader-Willi syndrome. ( 25900037 )
2015
136
A new look at weight loss surgery for children and adolescents with Prader-Willi syndrome. ( 26507938 )
2015
137
Psychiatric disorders in children with Prader-Willi syndrome-Results of a 2-year longitudinal study. ( 25712902 )
2015
138
EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME. ( 27570781 )
2015
139
Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome. ( 28943610 )
2015
140
Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome. ( 28943631 )
2015
141
Risk assessment of medically assisted reproduction and advanced maternal ages in the development of Prader-Willi syndrome due to UPD(15)mat. ( 26526156 )
2015
142
Polyhydramnios associated with Prader-Willi syndrome. ( 26271012 )
2015
143
Prediction of basal metabolic rate in patients with Prader-Willi syndrome. ( 26395435 )
2015
144
Increased plasma chemokine levels in children with Prader-Willi syndrome. ( 25691409 )
2015
145
Polyhydramnios associated with Prader-Willi syndrome. ( 26291428 )
2015
146
Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study. ( 26431633 )
2015
147
Prader-Willi syndrome can be diagnosed prenatally. ( 25338954 )
2014
148
Testes in Infants with Prader-Willi Syndrome: Human Chorionic Gonadotropin Treatment, Surgery and Histology. ( 25109686 )
2014
149
Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype. ( 24311433 )
2014
150
Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome. ( 25129202 )
2014
151
Characterization of minipuberty in infants with prader-willi syndrome. ( 25170853 )
2014
152
Prenatal diagnosis of Prader-Willi syndrome and Angelman syndrome for fetuses with suspicious deletion of chromosomal region 15q11-q13. ( 24434231 )
2014
153
What is the value of growth hormone therapy in Prader Willi syndrome? ( 24162007 )
2014
154
Growth hormone treatment for osteoporosis in patients with scoliosis of Prader-Willi syndrome. ( 25257562 )
2014
155
Differential regulation of non-protein coding RNAs from Prader-Willi Syndrome locus. ( 25246219 )
2014
156
An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome. ( 24311388 )
2014
157
Temper outbursts in Prader-Willi syndrome: causes, behavioural and emotional sequence and responses by carers. ( 23374136 )
2014
158
Prader-Willi syndrome and Tay-Sachs disease in association with mixed maternal uniparental isodisomy and heterodisomy 15 in a girl who also had isochromosome Xq. ( 25287655 )
2014
159
Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs. ( 24760766 )
2014
160
Comparative analysis of autistic traits and behavioral disorders in Prader-Willi syndrome and Asperger disorder. ( 25388910 )
2014
161
Congenital hepatic fibrosis in a child with Prader-Willi syndrome: a novel association. ( 24658561 )
2014
162
Disease-specific growth charts for Korean infants with Prader-Willi syndrome. ( 25339260 )
2014
163
Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. ( 24406482 )
2014
164
Assessment of Pretend Play in Prader-Willi Syndrome: A Direct Comparison to Autism Spectrum Disorder. ( 25241008 )
2014
165
The imprinted NPAP1 gene in the Prader-Willi syndrome region belongs to a POM121-related family of retrogenes. ( 24482533 )
2014
166
Long-term outcome of epilepsy in patients with Prader-Willi syndrome. ( 25326049 )
2014
167
Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. ( 25355237 )
2014
168
Prevalence of Prader-Willi syndrome among infants with hypotonia. ( 24582009 )
2014
169
Clinical and genetic features of Prader-Willi syndrome in China. ( 23933672 )
2014
170
Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome. ( 25263744 )
2014
171
Genetic Differentiation of Hypothalamus Parentally Biased Transcripts in Populations of the House Mouse Implicate the Prader-Willi Syndrome Imprinted Region as a Possible Source of Behavioral Divergence. ( 25172960 )
2014
172
Prader-Willi syndrome: a single center's experience in Korea. ( 25114691 )
2014
173
Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion. ( 24363065 )
2014
174
Ageing in people with Prader-Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults. ( 25088280 )
2014
175
The characteristics of scoliosis in Prader-Willi syndrome (PWS): analysis of 58 scoliosis patients with PWS. ( 25253244 )
2014
176
The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. ( 24816254 )
2014
177
Reduced cortical complexity in children with Prader-Willi Syndrome and its association with cognitive impairment and developmental delay. ( 25226172 )
2014
178
Velopharyngeal dysfunction in children with Prader-Willi syndrome after adenotonsillectomy. ( 25130946 )
2014
179
The use of medical care and the prevalence of serious illness in an adult Prader-Willi syndrome cohort. ( 23792791 )
2013
180
Birth seasonality in Prader-Willi syndrome resulting from chromosome 15 microdeletion. ( 23650177 )
2013
181
Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. ( 23893676 )
2013
182
Evaluating the frequency and characteristics of seizures in 142 Japanese patients with Prader-Willi syndrome. ( 23824702 )
2013
183
Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features. ( 24038875 )
2013
184
Central adrenal insufficiency in young adults with Prader-Willi syndrome. ( 23311724 )
2013
185
Mosaic maternal uniparental disomy of chromosome 15 in Prader-Willi syndrome: utility of genome-wide SNP array. ( 23225330 )
2013
186
Social responsiveness and competence in Prader-Willi syndrome: direct comparison to autism spectrum disorder. ( 22576167 )
2013
187
Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial. ( 23886754 )
2013
188
Regional cerebral blood flow and abnormal eating behavior in Prader-Willi syndrome. ( 22921862 )
2013
189
Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. ( 24001750 )
2013
190
The Mini-Gastric Bypass in the Management of Morbid Obesity in Prader-Willi Syndrome: A Viable Option? ( 24063639 )
2013
191
Stochastic loss of silencing of the imprinted Ndn/NDN allele, in a mouse model and humans with prader-willi syndrome, has functional consequences. ( 24039599 )
2013
192
The efficacy and safety of long-term NorditropinAr treatment in children with Prader-Willi syndrome. ( 23632904 )
2013
193
Sleep evaluation by actigraphy for children with Prader-Willi syndrome. ( 23623528 )
2013
194
'A one-sided affair': unilateral pulmonary oedema and the role of cardiac MRI in diagnosing premature coronary artery disease in a patient with Prader-Willi syndrome. ( 23704427 )
2013
195
Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. ( 23239671 )
2013
196
Prader-Willi syndrome - care of adults in general practice. ( 23529462 )
2013
197
Exploring patterns of unwanted behaviours in adults with Prader-Willi syndrome. ( 23613474 )
2013
198
Assessment of executive functions in Prader-Willi syndrome and relationship with intellectual level. ( 23606605 )
2013
199
Blount disease in a case of Prader-Willi syndrome: why is it not as prevalent as in obesity without Prader-Willi syndrome? ( 21874608 )
2013
200
Prader-willi syndrome: A case report and a Chinese literature review. ( 25343115 )
2013
201
Postprandial cardiac autonomic function in Prader-Willi syndrome. ( 23106348 )
2013
202
The fractal dimension approach in posture: a comparison between Down and Prader-Willi syndrome patients. ( 23360287 )
2013
203
Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis. ( 23781979 )
2013
204
Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. ( 23318724 )
2013
205
Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects--a meta analysis. ( 23967326 )
2013
206
Social and emotional processing in Prader-Willi syndrome: genetic subtype differences. ( 23536992 )
2013
207
Thyroid function from birth to adolescence in Prader-Willi syndrome. ( 23623517 )
2013
208
Molecular characterization of a patient presumed to have prader-willi syndrome. ( 23700380 )
2013
209
Regulatory elements associated with paternally-expressed genes in the imprinted murine Angelman/Prader-Willi syndrome domain. ( 23390487 )
2013
210
Altered functional brain networks in Prader-Willi syndrome. ( 23335390 )
2013
211
A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome. ( 23078343 )
2013
212
Frequency of Prader-Willi syndrome in births conceived via assisted reproductive technology. ( 23928912 )
2013
213
Effects of adiposity and Prader-Willi Syndrome on postexercise heart rate recovery. ( 23762535 )
2013
214
Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. ( 24038925 )
2013
215
Growth hormone, gender and face shape in Prader-Willi syndrome. ( 23918156 )
2013
216
An analysis of the topography, severity, potential sources of reinforcement, and treatments utilized for skin picking in Prader-Willi syndrome. ( 23810929 )
2013
217
Successful treatment of heart failure in an adult patient with Prader-Willi syndrome. ( 23545673 )
2013
218
Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome. ( 23696513 )
2013
219
Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome. ( 24144356 )
2013
220
Central sleep-disordered breathing and the effects of oxygen therapy in infants with Prader-Willi syndrome. ( 23761691 )
2013
221
Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD. ( 23436915 )
2013
222
Advanced maternal age at childbirth and the development of uniparental disomy. A commentary on the proportion of uniparental disomy is increased in Prader-Willi syndrome due to an advanced maternal childbearing age in Korea. ( 23364392 )
2013
223
Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy. ( 22947651 )
2013
224
Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study. ( 23897656 )
2013
225
Update on body composition and bone density in children with Prader-Willi syndrome. ( 23615452 )
2013
226
Leptin signaling defects in a mouse model of Prader-Willi syndrome: An orphan genetic obesity syndrome no more? ( 25002992 )
2013
227
Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader-Willi syndrome. ( 24139709 )
2013
228
Metabolic syndrome in adult patients with Prader-Willi syndrome. ( 23220075 )
2013
229
Expressive and receptive language in Prader-Willi syndrome: report on genetic subtype differences. ( 23295077 )
2013
230
Prader-Willi syndrome and growth hormone therapy: take a deep breath and weigh the data. ( 23102794 )
2013
231
Unexpectedly increased anorexigenic postprandial responses of PYY and GLP-1 to fast ice-cream consumption in adult patients with Prader-Willi syndrome. ( 24372155 )
2013
232
Examining the relationship between heart rate and problem behavior: a case study of severe skin picking in prader-willi syndrome. ( 24432859 )
2013
233
A longitudinal follow-up study of people with Prader-Willi syndrome with psychosis and those at increased risk of developing psychosis due to genetic subtype. ( 24330817 )
2013
234
Endocrine manifestations and management of Prader-Willi syndrome. ( 23962041 )
2013
235
Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood. ( 23284006 )
2013
236
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: Results from a 12-month prospective study. ( 24360789 )
2013
237
Expanded Prader-Willi syndrome due to chromosome 15q11.2-14 deletion: report and a review of literature. ( 23633107 )
2013
238
A Xq21.31 duplication without features of Prader-Willi syndrome. ( 22763470 )
2013
239
Epilepsy in Prader-Willi syndrome: experience of a national referral centre. ( 23750756 )
2013
240
Laparoscopic sleeve gastrectomy in Chinese female patient with Prader-Willi syndrome and diabetes. ( 22951076 )
2013
241
Growth hormone in health and disease: Consensus guidelines for GH therapy in Prader-Willi syndrome--this way forward? ( 23609333 )
2013
242
Prader-Willi syndrome and sleep-disordered breathing. ( 24126982 )
2013
243
Good cognitive performances in a child with Prader-Willi syndrome. ( 24238393 )
2013
244
The proportion of uniparental disomy is increased in Prader-Willi syndrome due to an advanced maternal childbearing age in Korea. ( 23303386 )
2013
245
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. ( 23543664 )
2013
246
Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. ( 23782572 )
2013
247
The impact of Prader-Willi syndrome on the family's quality of life and caregiving, and the unaffected siblings' psychosocial adjustment. ( 23057501 )
2013
248
Change in prevalence of congenital defects in children with Prader-Willi syndrome. ( 23296430 )
2013
249
Differential gene expression reveals mitochondrial dysfunction in an imprinting center deletion mouse model of Prader-Willi syndrome. ( 24127921 )
2013
250
Growth hormone in health and disease: Prader-Willi syndrome--GH therapy and bone. ( 23568440 )
2013
251
Effects of growth hormone treatment in adults with Prader-Willi syndrome. ( 23433655 )
2013
252
Behavioural and cognitive profiles of mouse models for Prader-Willi syndrome. ( 21971015 )
2013
253
Medical management for adults with Prader-Willi syndrome. ( 23869419 )
2013
254
Impaired theory of mind and symptoms of Autism Spectrum Disorder in children with Prader-Willi syndrome. ( 23792373 )
2013
255
Recommendations for the investigation of animal models of Prader-Willi syndrome. ( 23609791 )
2013
256
The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences. ( 24090687 )
2013
257
Behavioral profile of adults with Prader-Willi syndrome: correlations with individual and environmental variables. ( 23919902 )
2013
258
Mouse models of Prader-Willi Syndrome: a systematic review. ( 23391702 )
2013
259
Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy? ( 23438058 )
2013
260
Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy through adulthood. ( 23150680 )
2013
261
A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation. ( 23856564 )
2013
262
Central precocious puberty in a girl with Prader-Willi syndrome. ( 23740678 )
2013
263
Nocturnal sleep measured by actigraphy in children with Prader-Willi syndrome. ( 23102789 )
2013
264
Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome. ( 22664655 )
2012
265
Outcomes of adenotonsillectomy in patients with prader-willi syndrome. ( 23165379 )
2012
266
Spread of X-chromosome inactivation into chromosome 15 is associated with Prader-Willi syndrome phenotype in a boy with a t(X;15)(p21.1;q11.2) translocation. ( 21735174 )
2012
267
Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study. ( 22723315 )
2012
268
Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. ( 22188746 )
2012
269
An unexpected function of the Prader-Willi syndrome imprinting center in maternal imprinting in mice. ( 22496793 )
2012
270
The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction. ( 22559970 )
2012
271
Prader-Willi syndrome. ( 22237428 )
2012
272
A clinical follow-up of 35 Brazilian patients with Prader-Willi syndrome. ( 22948460 )
2012
273
The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review. ( 22652271 )
2012
274
Cardiac evaluation in children with Prader-Willi syndrome. ( 22181352 )
2012
275
Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome. ( 23083028 )
2012
276
Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. ( 21718342 )
2012
277
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study. ( 22081257 )
2012
278
Scoliosis in Prader-Willi syndrome: effect of growth hormone therapy and value of paravertebral muscle volume by CT in predicting scoliosis progression. ( 22678776 )
2012
279
Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment. ( 22844316 )
2012
280
Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. ( 22024642 )
2012
281
Nutritional and metabolic findings in patients with Prader-Willi syndrome diagnosed in early infancy. ( 23329756 )
2012
282
The effect of growth hormone on sleep-related cardio-respiratory control in Prader-Willi syndrome. ( 22385467 )
2012
283
Mental health problems in children with prader-willi syndrome. ( 22876265 )
2012
284
Enhanced appetitive learning and reversal learning in a mouse model for Prader-Willi syndrome. ( 22642890 )
2012
285
Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. ( 22045295 )
2012
286
Experience of severe desaturation during anesthetic induction period in an obese adult patient with Prader-Willi syndrome -A case report-. ( 22379576 )
2012
287
Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. ( 22508707 )
2012
288
POI: a score to modulate GH treatment in children with Prader-Willi syndrome. ( 22986481 )
2012
289
Anesthetic management of Prader-Willi syndrome: what if neuromuscular relaxants could not be avoided? ( 22198218 )
2012
290
Aging in Prader-Willi syndrome: twelve persons over the age of 50 years. ( 22585395 )
2012
291
Muscle-bone characteristics in children with Prader-Willi syndrome. ( 22162467 )
2012
292
Salivary flow rate and oral findings in Prader-Willi syndrome: a case-control study. ( 21702855 )
2012
293
Cutaneous manifestations of Prader-Willi syndrome. ( 23094311 )
2012
294
Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. ( 22117629 )
2012
295
Analysis of endothelial protein C receptor gene and metabolic profile in Prader-Willi syndrome and obese subjects. ( 22193922 )
2012
296
The imprinted NPAP1/C15orf2 gene in the Prader-Willi syndrome region encodes a nuclear pore complex associated protein. ( 22694955 )
2012
297
Multidisciplinary care in the intensive care unit for a patient with Prader-Willi syndrome: a dental approach. ( 23917721 )
2012
298
Intraoperative adrenal insufficiency in a patient with prader-willi syndrome. ( 23024738 )
2012
299
The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. ( 22785236 )
2012
300
Childhood subdural hemorrhage, macrocephaly, and coagulopathy associated with Prader-Willi syndrome: case report and review of the literature. ( 22704020 )
2012
301
Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese. ( 22923339 )
2012
302
Development and implementation of electronic growth charts for infants with Prader-Willi syndrome. ( 22903930 )
2012
303
Growth and development: growth hormone therapy improves cognition in children with Prader-Willi syndrome. ( 22565027 )
2012
304
Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi Syndrome. ( 22960339 )
2012
305
Coronary artery dissection in Prader-Willi syndrome: case report and literature review. ( 22857901 )
2012
306
General anesthetic management of Prader-Willi syndrome patient undergoing middle cerebral artery-superficial temporal artery anastomosis. ( 22870373 )
2012
307
Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome. ( 21977908 )
2012
308
Prader-willi syndrome: clinical aspects. ( 23133744 )
2012
309
Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. ( 22150958 )
2012
310
Pneumatosis intestinalis due to rotavirus infection in a child with Prader-Willi syndrome. ( 23692801 )
2012
311
Energy homeostasis in Prader-Willi syndrome: how clinical research informs studies of animal models of genetic obesity: comment on "Nutritional phases in Prader-Willi syndrome," Miller et al., 2011. Am J Med Genet Part A, 155:1040-1049. ( 22419655 )
2012
312
Severe tooth wear in Prader-Willi syndrome. A case-control study. ( 22639910 )
2012
313
Growth hormone secretion and its effect on height in pediatric patients with different genotypes of Prader-Willi syndrome. ( 22585665 )
2012
314
Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome. ( 22822045 )
2012
315
Prader--Willi syndrome: 16-year experience in Hong Kong. ( 22685788 )
2012
316
The neuroanatomy of genetic subtype differences in Prader-Willi syndrome. ( 22241551 )
2012
317
Risk for ingestion of toxic substances in children with Prader-Willi syndrome. ( 22987600 )
2012
318
Approach to the child with prader-willi syndrome. ( 23129592 )
2012
319
Prader-Willi syndrome in Victoria: mortality and causes of death. ( 22697408 )
2012
320
De novo interstitial duplication of 15q11.2-q13.1 with complex maternal uniparental trisomy for the 15q11-q13 region in a patient with Prader-Willi syndrome. ( 22903639 )
2012
321
An immunological basis of hyperphagia driven by GABAergic dysfunction in Prader-Willi Syndrome. ( 22289342 )
2012
322
Long noncoding RNAs as sinks in Prader-Willi syndrome. ( 23102265 )
2012
323
Saliva in Prader-Willi syndrome: quantitative and qualitative characteristics. ( 22673752 )
2012
324
The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome. ( 21273761 )
2011
325
Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients. ( 21702900 )
2011
326
Prader-Willi Syndrome: Obesity due to Genomic Imprinting. ( 22043168 )
2011
327
Maternal age effect on the development of Prader-Willi syndrome resulting from upd(15)mat through meiosis 1 errors. ( 21633360 )
2011
328
Decrease in acetylcholinergic neurons in the pedunculopontine tegmental nucleus in a patient with Prader-Willi syndrome. ( 20880323 )
2011
329
Magel2, a Prader-Willi syndrome candidate gene, modulates the activities of circadian rhythm proteins in cultured cells. ( 22208286 )
2011
330
Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes. ( 20651469 )
2011
331
Systematic review of the clinical and genetic aspects of Prader-Willi syndrome. ( 21503198 )
2011
332
Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome. ( 21932585 )
2011
333
Copy number variations at the Prader-Willi syndrome region on chromosome 15 and associations with obesity in whites. ( 21233802 )
2011
334
Specific treatment of Prader-Willi syndrome through cyclical rehabilitation programmes. ( 21269146 )
2011
335
Sudden proximal spinal dislocation with complete spinal cord injury 1 week after spinal fusion in a child with Prader-Willi syndrome: a case report. ( 21394070 )
2011
336
Prader-Willi syndrome: A primer for clinicians. ( 22008714 )
2011
337
Can fetal ultrasound result in prenatal diagnosis of Prader-Willi syndrome? ( 21848014 )
2011
338
The relationship between specific cognitive impairment and behaviour in Prader-Willi syndrome. ( 21199046 )
2011
339
Repetitive behavior profiles: Consistency across autism spectrum disorder cohorts and divergence from Prader-Willi syndrome. ( 21881965 )
2011
340
Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding. ( 20680019 )
2011
341
Nutritional phases in Prader-Willi syndrome. ( 21465655 )
2011
342
PET scan perfusion imaging in the Prader-Willi syndrome: new insights into the psychiatric and social disturbances. ( 20588317 )
2011
343
Oral mucosa in children with Prader-Willi syndrome. ( 21457346 )
2011
344
Spatial competences in Prader-Willi syndrome: a radial arm maze study. ( 21541643 )
2011
345
Small gray matter volume in orbitofrontal cortex in Prader-Willi syndrome: a voxel-based MRI study. ( 20669168 )
2011
346
Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. ( 21671379 )
2011
347
Liraglutide therapy in Prader-Willi syndrome. ( 21388446 )
2011
348
Atypical pulmonary carcinoid tumour in a 28-year-old nonsmoker with Prader-Willi syndrome. ( 22045793 )
2011
349
Tryptophan for the treatment of excessive daytime sleepiness in Prader-Willi syndrome. ( 21532101 )
2011
350
Assessment of body composition using bioelectrical impedance analysis in Prader-Willi syndrome. ( 22118318 )
2011
351
Prader-Willi syndrome. ( 21952424 )
2011
352
Gait pattern in two rare genetic conditions characterized by muscular hypotonia: Ehlers-Danlos and Prader-Willi syndrome. ( 21454046 )
2011
353
Psychiatric illness in a cohort of adults with Prader-Willi syndrome. ( 21454045 )
2011
354
Pubarche and Serum Dehydroepiandrosterone Sulfate Levels in Children with Prader-Willi Syndrome. ( 21521261 )
2011
355
Growth standards of infants with Prader-Willi syndrome. ( 21402637 )
2011
356
Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. ( 20943780 )
2011
357
Treating diabetes mellitus in Prader-Willi syndrome with Exenatide. ( 21227526 )
2011
358
The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. ( 20962018 )
2011
359
Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. ( 21632815 )
2011
360
Physical health problems in adults with Prader-Willi syndrome. ( 21834028 )
2011
361
A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome. ( 22052808 )
2011
362
Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. ( 20980432 )
2011
363
Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome. ( 20924154 )
2011
364
Orofacial dysfunction in individuals with Prader-Willi syndrome assessed with NOT-S. ( 21426270 )
2011
365
Body image and sexual interests in adolescents and young adults with Prader-Willi syndrome. ( 21932584 )
2011
366
Carnitine and coenzyme Q10 levels in individuals with Prader-Willi syndrome. ( 21337696 )
2011
367
Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome. ( 21343540 )
2011
368
Severe neonatal-onset panniculitis in a female infant with Prader-Willi syndrome. ( 22052851 )
2011
369
Fractal dimension approach in postural control of subjects with Prader-Willi Syndrome. ( 21854639 )
2011
370
Behavioral phenotype in adults with Prader-Willi syndrome. ( 21227640 )
2011
371
Prader-Willi syndrome and autism spectrum disorders: an evolving story. ( 21858456 )
2011
372
A new deletion refines the boundaries of the murine Prader-Willi syndrome imprinting center. ( 21659337 )
2011
373
Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus. ( 22242001 )
2011
374
In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. ( 21722955 )
2011
375
Clinical reporta89health supervision for children with Prader-Willi syndrome. ( 21187304 )
2011
376
Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning. ( 21056055 )
2011
377
Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome. ( 20965292 )
2011
378
Periodontal disease in a patient with Prader-Willi syndrome: a case report. ( 21798057 )
2011
379
Care of the patient with Prader-Willi syndrome. ( 21786486 )
2011
380
Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. ( 20847547 )
2011
381
TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome. ( 21418060 )
2011
382
Managing Prader-Willi syndrome in families: an embodied exploration. ( 21216515 )
2011
383
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. ( 21664161 )
2011
384
Delayed response of amylin levels after an oral glucose challenge in children with Prader-Willi syndrome. ( 21319343 )
2011
385
Angelman syndrome and prenatally diagnosed Prader-Willi syndrome in first cousins. ( 21964995 )
2011
386
Trajectory and outcomes of speech language therapy in the Prader-Willi syndrome (PWS): case report. ( 21552737 )
2011
387
The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome. ( 21223969 )
2011
388
Premature birth with complicated perinatal course delaying diagnosis of prader-willi syndrome. ( 22606524 )
2011
389
Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. ( 20089384 )
2011
390
Recognition of emotion in facial expression by people with Prader-Willi syndrome. ( 21121995 )
2011
391
Characterization of diabetes mellitus in Japanese prader-willi syndrome. ( 23926392 )
2011
392
Delayed gastric emptying in patients with Prader Willi Syndrome. ( 21175084 )
2010
393
The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood. ( 19863636 )
2010
394
Rehabilitation priorities for individuals with Prader-Willi Syndrome. ( 20441438 )
2010
395
A 47, XXY patient and Xq21.31 duplication with features of Prader-Willi syndrome: results of array-based comparative genomic hybridization. ( 20960156 )
2010
396
Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. ( 20173020 )
2010
397
Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. ( 20926543 )
2010
398
Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database. ( 20395666 )
2010
399
Prader-Willi syndrome associated with dilated cardiomyopathy. ( 20723130 )
2010
400
Prader-Willi syndrome: sorting out the relationships between obesity, hypersomnia, and sleep apnea. ( 20814307 )
2010
401
Developmental profiles and mentality in preschool children with Prader-Willi syndrome: a preliminary study. ( 20804673 )
2010
402
Urinary incontinence in persons with Prader-Willi Syndrome. ( 20575983 )
2010
403
Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. ( 20444923 )
2010
404
The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood. ( 20041936 )
2010
405
Anesthesia for a 16-month-old patient with Prader-Willi syndrome. ( 20711615 )
2010
406
Lower brain-derived neurotrophic factor in patients with prader-willi syndrome compared to obese and lean control subjects. ( 20427492 )
2010
407
Prader-Willi syndrome: Methylation study or fluorescence in situ hybridization first? ( 21206709 )
2010
408
Obstructive sleep disorders in Prader-Willi syndrome: The role of surgery and growth hormone. ( 20880597 )
2010
409
Adrenal function and mortality in children and adolescents with Prader-Willi syndrome attending a single centre from 1991-2009. ( 20718763 )
2010
410
Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. ( 20019130 )
2010
411
Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome. ( 20588305 )
2010
412
TPH2 polymorphisms and expression in Prader-Willi syndrome subjects with differing genetic subtypes. ( 22127900 )
2010
413
The C15orf2 gene in the Prader-Willi syndrome region is subject to genomic imprinting and positive selection. ( 20020165 )
2010
414
New onset epilepsy in Prader-Willi syndrome: semiology and literature review. ( 20837313 )
2010
415
Maternal parenting stress in families with a child with Angelman syndrome or Prader-Willi syndrome. ( 20809878 )
2010
416
Behavioural and cognitive abnormalities in an imprinting centre deletion mouse model for Prader-Willi syndrome. ( 20092561 )
2010
417
Cognitive profile in a large French cohort of adults with Prader-Willi syndrome: differences between genotypes. ( 20136683 )
2010
418
Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. ( 20394819 )
2010
419
Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome. ( 20545932 )
2010
420
Correlation between hyperghrelinemia and carotid artery intima-media thickness in children with Prader-Willi syndrome. ( 20376885 )
2010
421
Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. ( 20810574 )
2010
422
Treatment of scoliosis in patients affected with Prader-Willi syndrome using various techniques. ( 20550681 )
2010
423
The musculoskeletal manifestations of Prader-Willi syndrome. ( 20502241 )
2010
424
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. ( 20199883 )
2010
425
Prader-Willi syndrome and Angelman syndrome. ( 20803659 )
2010
426
Deletions and duplications of the 15q11-q13 region in spermatozoa from Prader-Willi syndrome fathers. ( 20083560 )
2010
427
Neurobehavioral phenotype in Prader-Willi syndrome. ( 20981773 )
2010
428
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. ( 20702523 )
2010
429
Perceptions of body image by persons with Prader-Willi syndrome and their parents. ( 20025358 )
2010
430
Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. ( 20560980 )
2010
431
Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. ( 20061431 )
2010
432
Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone Secretion Testing. ( 20368793 )
2010
433
Rehabilitation issues for children with Prader-Willi syndrome. ( 20067339 )
2010
434
Plasma adiponectin level and sleep structures in children with Prader-Willi syndrome. ( 19912511 )
2010
435
Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children. ( 20061428 )
2010
436
Prader-Willi syndrome, Snord115, and Htr2c editing. ( 19653017 )
2010
437
Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. ( 20956530 )
2010
438
Different distribution of the genetic subtypes of the Prader-Willi syndrome in the elderly. ( 20461108 )
2010
439
Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. ( 19946044 )
2010
440
Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome. ( 20158635 )
2010
441
Nutritient intake of young children with Prader-Willi syndrome. ( 20305754 )
2010
442
Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome. ( 20636465 )
2010
443
Dementia in a woman with Prader-Willi syndrome. ( 20219703 )
2010
444
Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype. ( 20727826 )
2010
445
Analysis of N- and O-linked protein glycosylation in children with Prader-Willi syndrome. ( 20825553 )
2010
446
Excessive appetitive arousal in Prader-Willi syndrome. ( 20005277 )
2010
447
Neural correlates of task switching in paternal 15q11-q13 deletion Prader-Willi syndrome. ( 20920489 )
2010
448
Improvement in quality of life after adenotonsillectomy in a child with Prader Willi syndrome. ( 19763652 )
2010
449
Precise microdeletion detection of Prader-Willi Syndrome with array comparative genome hybridization. ( 20708498 )
2010
450
An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype. ( 20082457 )
2010
451
A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome. ( 20405203 )
2010
452
Clinical management of behavioral characteristics of Prader-Willi syndrome. ( 20505842 )
2010
453
Perinatal dyskinesia as a presenting feature in Prader Willi syndrome. ( 18722147 )
2009
454
The foot in Prader-Willi syndrome: a case report. ( 19426385 )
2009
455
Bioenterics intragastric balloon may represent an alternative and effective treatment for body weight control in Prader-Willi syndrome. ( 19277798 )
2009
456
Dorsal and ventral stream mediated visual processing in genetic subtypes of Prader-Willi syndrome. ( 18950649 )
2009
457
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. ( 19837938 )
2009
458
A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signs. ( 20020576 )
2009
459
Mesangioproliferative glomerulonephritis in an infant with Prader-Willi syndrome. ( 19561787 )
2009
460
Water intake and risk of hyponatraemia in Prader-Willi syndrome. ( 19302470 )
2009
461
Task-switching deficits and repetitive behaviour in genetic neurodevelopmental disorders: data from children with Prader-Willi syndrome chromosome 15 q11-q13 deletion and boys with Fragile X syndrome. ( 19221920 )
2009
462
Maternal uniparental disomy 14 syndrome demonstrates prader-willi syndrome-like phenotype. ( 19800077 )
2009
463
Morbid obesity in an adolescent with Prader-Willi syndrome. ( 19543650 )
2009
464
Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment. ( 19027358 )
2009
465
Trisomy 9p and Prader-Willi syndromes in an infant resulting from a de-novo unbalanced t(9;15) translocation. ( 19282755 )
2009
466
Efficacy and safety of adenotonsillectomy for pediatric obstructive sleep apnea in Prader-Willi syndrome. ( 19462846 )
2009
467
"Efficacy of laparoscopic sleeve gastrectomy as a stand-alone technique for children with morbid obesity" and "BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits". ( 18982398 )
2009
468
The European Prader-Willi Syndrome Clinical Research Database: an aid in the investigation of a rare genetically determined neurodevelopmental disorder. ( 19457156 )
2009
469
Respiratory changes in Prader-Willi syndrome. ( 19224093 )
2009
470
Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. ( 19048015 )
2009
471
Inclusion of chiropractic care in multidisciplinary management of a child with Prader-Willi syndrome: a case report. ( 19948310 )
2009
472
Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. ( 19158197 )
2009
473
Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice. ( 19172181 )
2009
474
Relationship between the IQ of people with Prader-Willi syndrome and that of their siblings: evidence for imprinted gene effects. ( 19207281 )
2009
475
Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. ( 19421899 )
2009
476
Scatter plot analysis of excessive daytime sleepiness and severe disruptive behavior in adults with Prader-Willi syndrome: a pilot study. ( 18790602 )
2009
477
Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment. ( 18822426 )
2009
478
Transcranial direct current stimulation: a novel approach to control hyperphagia in Prader-Willi syndrome. ( 19406762 )
2009
479
Body mass index in children with Prader-Willi Syndrome during human growth hormone therapy: a real world situation. ( 19364570 )
2009
480
Variations in fetal phenotype in Prader-Willi syndrome. ( 19248040 )
2009
481
Morning melatonin levels in Prader-Willi syndrome. ( 19606476 )
2009
482
Influence of age, gender, and glucose tolerance on fasting and fed acylated ghrelin in Prader Willi syndrome. ( 19150743 )
2009
483
A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome. ( 19066619 )
2009
484
GH treatment reduces total ghrelin in Prader-Willi syndrome (PWS) and may confound ghrelin studies in young PWS children. ( 19178506 )
2009
485
Breathing deficits of the Prader-Willi syndrome. ( 19712904 )
2009
486
A specific pathway can be identified between genetic characteristics and behaviour profiles in Prader-Willi syndrome via cognitive, environmental and physiological mechanisms. ( 19504726 )
2009
487
Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. ( 19401370 )
2009
488
Assessment of physical function in adults with Prader-Willi syndrome. ( 19479512 )
2009
489
Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. ( 18814886 )
2009
490
Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome. ( 19498323 )
2009
491
Is gestation in Prader-Willi syndrome affected by the genetic subtype? ( 19760168 )
2009
492
Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial. ( 19622627 )
2009
493
On the origin of sensory impairment and altered pain perception in Prader-Willi syndrome: a neurophysiological study. ( 18986815 )
2009
494
The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. ( 19383777 )
2009
495
Prader-Willi syndrome. ( 18781185 )
2009
496
A special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS). ( 19768349 )
2009
497
Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi Syndrome. ( 19729946 )
2009
498
Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. ( 18930956 )
2009
499
Characteristics and frequency of seizure disorder in 56 patients with Prader-Willi syndrome. ( 19533781 )
2009
500
Scoliosis in patients with Prader Willi Syndrome - comparisons of conservative and surgical treatment. ( 19419581 )
2009
501
Food addiction and cues in prader-willi syndrome. ( 21768997 )
2009
502
About the benefits of growth hormone treatment in children with Prader-Willi syndrome. ( 19364573 )
2009
503
Cortisol levels in Prader-Willi syndrome support changes in routine care. ( 19133690 )
2009
504
Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome. ( 19267411 )
2009
505
Complex rearrangements of chromosome 15 in two patients with mild/atypical Prader Willi syndrome. ( 18618997 )
2008
506
Pre-, peri- and postnatal complications in Prader-Willi syndrome in a UK sample. ( 17919850 )
2008
507
Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up. ( 18780599 )
2008
508
Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects. ( 18362510 )
2008
509
Prader Willi Syndrome and excessive daytime sleepiness. ( 18201664 )
2008
510
Molecular characterization of Prader-Willi syndrome by real-time PCR. ( 18554170 )
2008
511
Scoliosis in patients with Prader-Willi Syndrome. ( 18606625 )
2008
512
Is scoliosis an issue for giving growth hormone to children with Prader-Willi syndrome? ( 19028967 )
2008
513
The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation. ( 18557765 )
2008
514
Treatment of precocious puberty in a female with Prader-Willi syndrome. ( 18655533 )
2008
515
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome. ( 18997487 )
2008
516
Review of 64 cases of death in children with Prader-Willi syndrome (PWS). ( 18324685 )
2008
517
Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. ( 18603572 )
2008
518
Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome. ( 18567561 )
2008
519
Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region. ( 18226259 )
2008
520
The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. ( 18203198 )
2008
521
Strategies and correlates of jigsaw puzzle and visuospatial performance by persons with Prader-Willi syndrome. ( 18702555 )
2008
522
Cognition and behavior in pre-pubertal children with Prader-Willi syndrome and associations with sleep-related breathing disorders. ( 19006209 )
2008
523
BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. ( 18449615 )
2008
524
Lymphedema in Prader-Willi syndrome. ( 18986486 )
2008
525
A mindfulness-based health wellness program for an adolescent with Prader-Willi syndrome. ( 18285504 )
2008
526
Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). ( 18663319 )
2008
527
Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome. ( 18241068 )
2008
528
Analysis of the Prader-Willi syndrome chromosome region using quantitative microsphere hybridization (QMH) array. ( 18698613 )
2008
529
Scoliosis in Prader-Willi syndrome: prevalence, effects of age, gender, body mass index, lean body mass and genotype. ( 18263693 )
2008
530
Complications of scoliosis surgery in Prader-Willi syndrome. ( 18277871 )
2008
531
Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. ( 18363884 )
2008
532
Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome. ( 18301920 )
2008
533
Neurodevelopmental abnormalities in the brainstem of prenatal mice lacking the Prader-Willi syndrome gene Necdin. ( 18085261 )
2008
534
Prader-Willi syndrome: who can have growth hormone? ( 18089632 )
2008
535
Genetics and mathematics: evidence from Prader-Willi syndrome. ( 17845808 )
2008
536
Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. ( 18710462 )
2008
537
The oro-dental phenotype in Prader-Willi syndrome: a survey of 15 patients. ( 18086025 )
2008
538
Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. ( 18211968 )
2008
539
Testicular histology in boys with Prader-Willi syndrome: fertile or infertile? ( 18721940 )
2008
540
Everyday physical activity and adiposity in Prader-Willi syndrome. ( 19189698 )
2008
541
Prader-Willi syndrome phenocopy due to duplication of Xq21.1-q21.31, with array CGH of the critical region. ( 18279435 )
2008
542
French database of children and adolescents with Prader-Willi syndrome. ( 18831731 )
2008
543
Prader-Willi syndrome: is there a recognizable fetal phenotype? ( 18661490 )
2008
544
High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. ( 18303077 )
2008
545
Food-related neural circuitry in Prader-Willi syndrome: response to high- versus low-calorie foods. ( 18311513 )
2008
546
Critical analysis of bariatric procedures in Prader-Willi syndrome. ( 18162838 )
2008
547
Loss of the Prader-Willi syndrome protein necdin causes defective migration, axonal outgrowth, and survival of embryonic sympathetic neurons. ( 18570257 )
2008
548
Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. ( 18468308 )
2008
549
Light optical precision measurements of the active and inactive Prader-Willi syndrome imprinted regions in human cell nuclei. ( 18039333 )
2008
550
Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome. ( 18298478 )
2008
551
Behavior in Prader-Willi syndrome: relationship to genetic subtypes and age. ( 18665884 )
2008
552
Interdisciplinary behavioral intervention for life-threatening obesity in an adolescent with Prader-Willi syndrome - a case report. ( 18408535 )
2008
553
Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity. ( 17431897 )
2008
554
Persistent growth failure in Prader-Willi syndrome associated with short-chain acyl-CoA dehydrogenase gene variant. ( 18184946 )
2008
555
The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome. ( 18177526 )
2008
556
Frontal behavioral syndromes in Prader-Willi syndrome. ( 18262375 )
2008
557
'Hungry Eyes': visual processing of food images in adults with Prader-Willi syndrome. ( 18422527 )
2008
558
Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. ( 18031326 )
2008
559
In search of the psychosis gene in people with Prader-Willi syndrome. ( 18324689 )
2008
560
Necdin plays a role in the serotonergic modulation of the mouse respiratory network: implication for Prader-Willi syndrome. ( 18272695 )
2008
561
Hyperghrelinemia precedes obesity in Prader-Willi syndrome. ( 18460565 )
2008
562
Recommendations for the diagnosis and management of Prader-Willi syndrome. ( 18697869 )
2008
563
Conservative scoliosis treatment in patients with Prader-Willi syndrome. ( 18810044 )
2008
564
Molecular and clinical characterization of two patients with Prader-Willi syndrome and atypical deletions of proximal chromosome 15q. ( 18627056 )
2008
565
Foreign body aspiration in a boy with Prader-Willi Syndrome. ( 18204752 )
2008
566
Necdin gene, respiratory disturbances and Prader-Willi syndrome. ( 18085265 )
2008
567
Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. ( 18266248 )
2008
568
Quality of life assessment in a sample of patients affected by Prader-Willi syndrome. ( 17803668 )
2007
569
Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. ( 17304548 )
2007
570
DNA demethylation reactivation of imprinted genes in cell lines from patients with Prader-Willi syndrome and a mouse model. ( 17506103 )
2007
571
Deaths due to choking in Prader-Willi syndrome. ( 17036318 )
2007
572
Language development in a 3-year-old boy with Prader-Willi syndrome. ( 17453868 )
2007
573
Atypical presentation of Prader-Willi syndrome with cerebral venous thrombosis: association or fortuity? ( 18058630 )
2007
574
X-chromosome inactivation patterns in females with Prader-Willi syndrome. ( 17036338 )
2007
575
The relationship between compulsive behaviour and academic achievement across the three genetic subtypes of Prader-Willi syndrome. ( 17493030 )
2007
576
An obese female with Prader-Willi syndrome and daytime sleepiness. ( 17993048 )
2007
577
Thyroid function studies in Prader-Willi syndrome. ( 17304546 )
2007
578
Autistic-like symptomatology in Prader-Willi syndrome: a review of recent findings. ( 17389128 )
2007
579
Single-gene autosomal recessive disorders and Prader-Willi syndrome: an update for food and nutrition professionals. ( 17324666 )
2007
580
Prader-Willi syndrome in Taiwan. ( 17532839 )
2007
581
A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. ( 17223988 )
2007
582
Genotype and phenotype in patients with Prader-Willi syndrome in Taiwan. ( 17537021 )
2007
583
Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33-39). ( 17164585 )
2007
584
Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. ( 17158560 )
2007
585
Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. ( 17047025 )
2007
586
Screening of Prader-Willi syndrome and Angelman syndrome in school children with moderate to profound mental retardation in southern Taiwan. ( 17626606 )
2007
587
Eating behavior and gastric emptying in adults with Prader-Willi syndrome. ( 17622785 )
2007
588
Psychomotor development in infants with Prader-Willi syndrome and associations with sleep-related breathing disorders. ( 17597659 )
2007
589
Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome. ( 17337902 )
2007
590
Anthropometric and intellectual evaluation of individuals with Prader-Willi syndrome. ( 17588847 )
2007
591
Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. ( 17716335 )
2007
592
Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. ( 17728320 )
2007
593
Klinefelter's syndrome and Prader-Willi syndrome: a rare combination. ( 17657135 )
2007
594
Healthcare transition in persons with intellectual disabilities: general issues, the Maastricht model, and Prader-Willi syndrome. ( 17639594 )
2007
595
The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. ( 17181601 )
2007
596
Behavioral and psychiatric disorders in Prader-Willi syndrome: a population study in Japan. ( 17314021 )
2007
597
Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. ( 17666087 )
2007
598
Polysomnographic characteristics in patients with Prader-Willi syndrome. ( 17722117 )
2007
599
[Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy]. ( 17340066 )
2007
600
Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. ( 17103437 )
2007
601
Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. ( 17103434 )
2007
602
KIGS highlights: growth hormone treatment in Prader-Willi Syndrome. ( 18174707 )
2007
603
Nutrient intake and body composition variables in Prader-Willi syndrome--effect of growth hormone supplementation and genetic subtype. ( 17550213 )
2007
604
Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients. ( 17867985 )
2007
605
A Y/15 translocation in a 45,X male with Prader-Willi syndrome. ( 18286823 )
2007
606
Scoliosis associated with Prader-Willi syndrome. ( 17482119 )
2007
607
Prader-Willi syndrome: an update and review for the primary pediatrician. ( 17522286 )
2007
608
Whole genome microarray analysis of gene expression in Prader-Willi syndrome. ( 17236194 )
2007
609
Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome. ( 17036336 )
2007
610
Behavioral and emotional symptoms of children and adolescents with Prader-Willi Syndrome. ( 16941227 )
2007
611
Assessment of sleep and breathing in adults with prader-willi syndrome: a case control series. ( 18198805 )
2007
612
Introductory comments - special section: Prader-Willi syndrome. ( 17304547 )
2007
613
Expressive language in persons with Prader-Willi syndrome. ( 17515298 )
2007
614
Marked suppression of ghrelin concentration by insulin in Prader-willi syndrome. ( 17449920 )
2007
615
Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. ( 17567883 )
2007
616
Changing rates of genetic subtypes of Prader-Willi syndrome in the UK. ( 16957680 )
2007
617
Prader-Willi syndrome: medical prevention and behavioral challenges. ( 17562587 )
2007
618
Clinical evidence of intrauterine disturbance in Prader-Willi syndrome, a genetically imprinted neurodevelopmental disorder. ( 17055193 )
2007
619
Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin. ( 17085944 )
2007
620
Mosaic paternally derived inv dup(15) may partially rescue the Prader-Willi syndrome phenotype with uniparental disomy. ( 17850637 )
2007
621
Cardiac tamponade due to systemic lupus erythematosus in patient with Prader-Willi syndrome after growth hormone therapy. ( 17664237 )
2007
622
Oral diseases in a patient affected with Prader-Willi syndrome. ( 17571934 )
2007
623
Hypothyroidism in Prader-Willi syndrome: a case report and review of the literature. ( 17993776 )
2007
624
Prader-Willi syndrome. ( 17431078 )
2007
625
Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. ( 17264186 )
2007
626
Gastric rupture and necrosis in Prader-Willi syndrome. ( 17667731 )
2007
627
Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome. ( 17596650 )
2007
628
Molecular genetic diagnostics of Prader-Willi Syndrome: a validation of linkage analysis for the Chinese population. ( 17945167 )
2007
629
Treatment of Prader-Willi syndrome with growth hormone: merits and limits of postmarketing surveillance studies. ( 17237834 )
2007
630
Assessment of hyperphagia in Prader-Willi syndrome. ( 17636101 )
2007
631
Intracranial abnormalities detected by three-dimensional magnetic resonance imaging in Prader-Willi syndrome. ( 17103438 )
2007
632
The effect of growth hormone on the response of total and acylated ghrelin to a standardized oral glucose load and insulin resistance in children with Prader-Willi syndrome. ( 17192298 )
2007
633
Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study. ( 17163531 )
2007
634
Conditional cardiovascular response to growth hormone therapy in adult patients with Prader-Willi syndrome. ( 17264185 )
2007
635
Psychosis associated with fluoxetine in Prader-Willi syndrome. ( 17667473 )
2007
636
A 3 year old with obesity and hypotonia. Prader-Willi syndrome. ( 17515168 )
2007
637
Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. ( 17437511 )
2007
638
Sylvian fissure morphology in Prader-Willi syndrome and early-onset morbid obesity. ( 17700392 )
2007
639
A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. ( 17391252 )
2007
640
Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. ( 17407467 )
2007
641
Partial cerebellar hypoplasia in a patient with Prader-Willi syndrome. ( 16801186 )
2006
642
Prevalence of Angelman syndrome and Prader-Willi syndrome in Estonian children: sister syndromes not equally represented. ( 16906556 )
2006
643
Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. ( 17062796 )
2006
644
Prader-Willi syndrome due to uniparental disomy in a patient with a balanced chromosomal translocation. ( 17159828 )
2006
645
Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. ( 16231029 )
2006
646
Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome. ( 16507634 )
2006
647
Anesthesia and Prader-Willi syndrome: preliminary experience with regional anesthesia. ( 16879513 )
2006
648
Respiratory failure due to morbid obesity in a patient with Prader-Willi syndrome: an experience of long-term mechanical ventilation. ( 17072695 )
2006
649
Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. ( 16982806 )
2006
650
Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome. ( 17023209 )
2006
651
Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. ( 17003096 )
2006
652
Neural representations of hunger and satiety in Prader-Willi syndrome. ( 16276365 )
2006
653
Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome. ( 16374018 )
2006
654
Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome. ( 16995571 )
2006
655
Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. ( 16887432 )
2006
656
Recurrent panniculitis in an adolescent boy with Prader-Willi syndrome. ( 17052066 )
2006
657
Quantitative assay of deletion or duplication genotype by capillary electrophoresis system: Application in Prader-Willi syndrome and Duchenne muscular dystrophy. ( 17040959 )
2006
658
Ghrelin levels in young children with Prader-Willi syndrome. ( 16887433 )
2006
659
An investigation into food preferences and the neural basis of food-related incentive motivation in Prader-Willi syndrome. ( 16901290 )
2006
660
Normal minipuberty of infancy in boys with Prader-Willi syndrome. ( 17137911 )
2006
661
Management of obesity in Prader-Willi syndrome. ( 17082801 )
2006
662
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). ( 16886957 )
2006
663
Obstructive sleep apnea syndrome in Prader-Willi Syndrome: an unrecognized and untreated cause of cognitive and behavioral deficits? ( 17109239 )
2006
664
Near demise of a child with Prader-Willi syndrome during elective orchidopexy. ( 16879524 )
2006
665
Quantitative analysis of SNRPN(correction of SRNPN) gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. ( 16574761 )
2006
666
Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. ( 16984242 )
2006
667
A non-obese boy with Prader-Willi syndrome shows cardiopulmonary impairment due to severe kyphoscoliosis. ( 16906551 )
2006
668
Brain developmental abnormalities in Prader-Willi syndrome detected by diffusion tensor imaging. ( 16882785 )
2006
669
Behavioral features of CHARGE syndrome (Hall-Hittner syndrome) comparison with Down syndrome, Prader-Willi syndrome, and Williams syndrome. ( 15637708 )
2005
670
Electroclinical characteristics of seizures-comparing Prader--Willi syndrome with Angelman syndrome. ( 15668048 )
2005
671
Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models. ( 16075369 )
2005
672
The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. ( 15985489 )
2005
673
Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome. ( 15754036 )
2005
674
Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients. ( 15657368 )
2005
675
Hypocretin deficiency in Prader-Willi syndrome. ( 15613151 )
2005
676
Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. ( 15870134 )
2005
677
Increased density of ghrelin-expressing cells in the gastric fundus and body in Prader-Willi syndrome. ( 15956087 )
2005
678
Unexpected death due to refractory metabolic acidosis and massive hemolysis in a young infant with Prader-Willi syndrome. ( 15523631 )
2005
679
Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. ( 15565282 )
2005
680
Children with Prader-Willi syndrome vs. Williams syndrome: indirect effects on parents during a jigsaw puzzle task. ( 16287481 )
2005
681
The Prader-Willi syndrome murine imprinting center is not involved in the spatio-temporal transcriptional regulation of the Necdin gene. ( 15634360 )
2005
682
The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. ( 16030173 )
2005
683
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. ( 15687345 )
2005
684
Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. ( 15506676 )
2004
685
Correlation between fasting plasma ghrelin levels and age, body mass index (BMI), BMI percentiles, and 24-hour plasma ghrelin profiles in Prader-Willi syndrome. ( 15292322 )
2004
686
A familial balanced inverted insertion ins(15)(q15q13q11.2) producing Prader-Willi syndrome, Angelman syndrome and duplication of 15q11.2-q13 in a single family: Importance of differentiation from a paracentric inversion. ( 15039970 )
2004
687
Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. ( 15476445 )
2004
688
Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome. ( 15292365 )
2004
689
Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. ( 14700552 )
2004
690
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. ( 15070936 )
2004
691
Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome. ( 15057669 )